A 52-year-old woman has lost both of her sisters and her mother to breast cancer. The patient states, "My doctor wants me to take tamoxifen to help prevent breast cancer. What do you think?" Which of the following is your best response?
A) "We call this drug a chemotherapy agent."
B) "Tamoxifen prevent osteoporosis."
C) "I would recommend raloxifene."
D) "Tamoxifen reduces the incidence by 49%."
Ans: D
Feedback: Tamoxifen reduces breast cancer incidence by 49%. Tamoxifen is referred to as a chemopreventive agent, not a chemotherapeutic agent. It does prevent osteoporosis, but this response does not address breast cancer prevention. Raloxifene (Evista) is another drug that shows promise as a chemopreventive agent.
You might also like to view...
A client is admitted with superior vena cava syndrome. What action by the nurse is most appropriate?
a. Administer a dose of allopurinol (Aloprim). b. Assess the client's serum potassium level. c. Gently inquire about advance directives. d. Prepare the client for emergency surgery.
Which of the following clients may be experiencing a sensory focal seizure that has sent an abnormal cortical discharge to the autonomic nervous system (ANS)?
A) A 44-year old patient complaining of constant movement and pain in the legs that gets worse when he tries to sleep B) An 85-year-old patient experiencing drooping of the right side of the face and numbness in the right arm and leg C) A 56-year-old complaining of tingling sensations and has both an elevated pulse and BP D) A 22-year-old complaining of a stiff neck and achiness, along with some nausea and vomiting
When the nurse reads an article and uses the findings of a study to improve the quality of the patients for whom she cares, she is implementing the role of:
a) teacher b) manager c) research consumer d) advocate
The nurse is caring for a patient taking trovafloxacin (Trovan) for an infection. The nurse understands that the greatest concern with using trovafloxacin and alatrofloxacin is the develop-ment of
a. hepatotoxicity. b. weight loss. c. visual disturbances. d. anemia.